Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma

Affiliations

¹ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China.
² Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China.
³ Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China.
⁴ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China. yexiong12@163.com.
⁵ Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China. wangliangtrhos@126.com.
⁶ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China. medata@163.com.

^# Contributed equally.

Lin-Rui Gao et al. Leukemia. 2024 Apr.

. 2024 Apr;38(4):914-917.

doi: 10.1038/s41375-024-02227-5. Epub 2024 Mar 19.

¹ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China.
² Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China.
³ Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China.
⁴ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China. yexiong12@163.com.
⁵ Department of Hematology, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730, China. wangliangtrhos@126.com.
⁶ Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100021, China. medata@163.com.

^# Contributed equally.

No abstract available

References

1. Moslehi R, Devesa SS, Schairer C, Fraumeni JF. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936–9. - DOI - PubMed
1. Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T, et al. Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: a SEER database analysis (2000-2015). Radiother Oncol. 2022;173:179–87. - DOI - PubMed
1. Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88:642–9. - DOI - PubMed
1. Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjo LD, et al. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2021;105:914–20. - DOI - PubMed
1. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: B-cell lymphomas, Version 3, 2023. https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf .